IN
Amplia Therapeutics Limited
INNMF · OTC
$0.08 +6.31% (+$0.00)
1M -20.52%
Market Cap $60.2M
P/E Ratio -
Div. Yield -
ROE 22.61%
Piotroski F-Score Weak
1/9Valuation
35 /100
Fair P/B 2.86x
P/S 15.90x
P/FFO N/A
Growth
82 /100
Growing Book val. growth 1.27%
Rev. growth 24.02%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 172.22%
Gross margin 94.43%
FCF margin 182.04%
Quality
2 /100
Poor ROA 28.65%
ROIC 30.94%
Asset turnover 0.16x
Debt
100 /100
Low Current ratio 7.91x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
34 /100
Moderate EPS volatility 28.77%
Beta -0.40x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre INNMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Burns
Employees
1
Headquarters
Melbourne
Evenimente viitoare
27 NOV.
Earnings
Upcoming earnings report